Journal Guide

Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, research articles, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of the latest Internet technology for both the submission and review of manuscripts. The journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

Materials Advances is an international, gold open access journal, publishing high-quality research across the breadth of materials science. The journal accepts experimental or theoretical studies that report new understanding, applications, properties and synthesis of materials, building on and complementing the materials content already published across the Royal Society of Chemistry journal portfolio. Submissions are handled by our high profile associate editors, all of whom also look after submissions to Journal of Materials Chemistry A, B & C. The Materials Advances publishing experience comes with the reputation, standards, commitment and expertise you would expect from an RSC journal, plus the visibility boost that comes from being open access and part of the Journal of Materials Chemistry family.

Our aim is to encourage chemists to publish as much as possible their experimental detail, particularly synthetic procedures and characterization information. There is no restriction on the length of the experimental section. In addition, availability of compound samples is published and considered as important information. Authors are encouraged to register or deposit their chemical samples through the non-profit international organization Molecular Diversity Preservation International (MDPI).

Nano Today is the international journal for researchers with interests across the whole of nanoscience and technology. Through its unique mixture of peer-reviewed articles, the latest research news, and information on key developments, Nano Today provides comprehensive coverage of this exciting and dynamic new field.Description:Nano Today publishes original articles on all aspects of nanoscience and nanotechnology. Manuscripts of three types are considered: Review Articles that inform readers of the latest research and advances in nanoscience and nanotechnology, Rapid Communications that feature exciting research breakthroughs in the field, and News and Opinions that comment on topical issues or express views on the developments in related fields.Contributions include a variety of topics such as:• Synthesis and Self-Assembly of Nanostructured Materials and Films• Functionalization and Size-Dependent Properties of Nanocrystals, Quantum Dots and Nanowires• Processing and Templating of Nanotubes and Nanoporous Materials• Tailoring of Polymeric Nanoparticles, Organic-Inorganic Nanocomposites and Biohybrids• Fabrication of Nano and Micro Electro Mechanical Systems• Design and Engineering of Structural and Functional Nanomaterials• Nanosystems for Biological, Medical, Chemical, Catalytic, Energy and Environmental Applications• Nanodevices for Electronic, Photonic, Magnetic, Imaging, Diagnostic and Sensor Applications

The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine.Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases. In addition to bimonthly issues, the journal website (http://www.nanomedjournal.com) also presents important nanomedicine-related information, such as future meetings, meeting summaries, funding opportunities, societal subjects, public health, and ethical issues of nanomedicine.The potential scope of nanomedicine is broad, and we expect it to eventually involve all aspects of medicine. Sub-categories include synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; interactions of nanomaterials with cells, tissues, and living organisms; regenerative medicine; public health; toxicology; point of care monitoring; nutrition; nanomedical devices; prosthetics; biomimetics; and bioinformatics.Article formats include Communications, Original Articles, Reviews, Perspectives, Technical and Commercialization Notes, and Letters to the Editor. We invite authors to submit original manuscripts in these categories. The journal website (http://www.nanomedjournal.com) also presents important nanomedicine-related information, such as future meetings, meeting summaries, funding opportunities, societal subjects, public health, and ethical issues of nanomedicine.

NJC (New Journal of Chemistry) is a broad-based primary journal encompassing all branches of chemistry and its sub-disciplines. It publishes high-quality work that opens new directions in chemistry or in other scientific disciplines. Research must demonstrate that it will have an impact on areas of research other than that of the reported work.

OpenNano is an internationally peer-reviewed and open access journal publishing high-quality review articles and original research papers on the burgeoning area of nanopharmaceutics and nanosized delivery systems for drugs, genes, and imaging agents. The Journal publishes basic, translational and clinical research as well as methodological papers and aims to bring together chemists, biochemists, cell biologists, material scientists, pharmaceutical scientists, pharmacologists, clinicians and all others working in this exciting and challenging area.

Pharmaceutical Biology will publish manuscripts describing the discovery, methods for discovery, description, analysis characterization, and production/isolation (including sources and surveys) of biologically-active chemicals or other substances, drugs, pharmaceutical products, or preparations utilized in systems of traditional medicine.Topics may generally encompass any facet of natural product research related to pharmaceutical biology. Papers dealing with agents or topics related to natural product drugs are also appropriate (e.g., semi-synthetic derivatives). Manuscripts will be published as reviews, perspectives, regular research articles, and short communications. The primary criteria for acceptance and publication are scientific rigor and potential to advance the field.Read More: http://informahealthcare.com/page/phb/Description.

Pharmaceutical Development and Technology publishes research in the design, development, manufacture, and evaluation of traditional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems.Through basic and applied research articles, review papers, short reports, and book reviews, Pharmaceutical Development and Technology covers topics such as: *Preformulation evaluation of pharmaceutical materials *Physical pharmacy and formulation *Research process engineering and scale-up of drug delivery systems *Drug delivery systems evaluation and quality improvement *Global standardization of pharmaceutical information.